FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200183429> ?p ?o ?g. }

• W4200183429 abstract "Objective: Sepsis is life threatening and leads to complex inflammation in patients with immunocompromised conditions, such as cancer, and receiving immunosuppressants for autoimmune diseases and organ transplant recipients. Increasing evidence has shown that RNA-Sequencing (RNA-Seq) can be used to define subendotype in patients with sepsis; therefore, we aim to use RNA-Seq to identify transcriptomic features among immunocompromised patients with sepsis. Methods: We enrolled patients who were admitted to medical intensive care units (ICUs) for sepsis at a tertiary referral centre in central Taiwan. Whole blood on day-1 and day-8 was obtained for RNA-Seq. We used Gene Set Enrichment Analysis (GSEA) to identify the enriched pathway of day-8/day-1 differentially expressed genes and MiXCR to determine the diversity of T cell repertoire. Results: A total of 18 immunocompromised subjects with sepsis and 18 sequential organ failure assessment (SOFA) score-matched immunocompetent control subjects were enrolled. The ventilator-day, ICU-stay, and hospital-day were similar between the two groups, whereas the hospital mortality was higher in immunocompromised patients than those in immunocompetent patients (50.0 vs. 5.6%, p < 0.01). We found that the top day-8/day-1 upregulated genes in the immunocompetent group were mainly innate immunity and inflammation relevant genes, namely, PRSS33, HDC, ALOX15, FCER1A, and OLR1, whereas a blunted day-8/day-1 dynamic transcriptome was found among immunocompromised patients with septic. Functional pathway analyses of day-8/day-1 differentially expressed genes identified the upregulated functional biogenesis and T cell-associated pathways in immunocompetent patients recovered from sepsis, whereas merely downregulated metabolism-associated pathways were found in immunocompromised patients with septic. Moreover, we used MiXCR to identify a higher diversity of T cell receptor (TCR) in immunocompetent patients both on day-1 and on day-8 than those in immunocompromised patients. Conclusions: Using RNA-Seq, we found compromised T cell function, altered metabolic signalling, and decreased T cell diversity among immunocompromised patients with septic, and more mechanistic studies are warranted to elucidate the underlying mechanism." @default.
• W4200183429 created "2021-12-31" @default.
• W4200183429 creator A5002450833 @default.
• W4200183429 creator A5006795311 @default.
• W4200183429 creator A5016522091 @default.
• W4200183429 creator A5037349631 @default.
• W4200183429 creator A5041558983 @default.
• W4200183429 creator A5042866937 @default.
• W4200183429 creator A5065486587 @default.
• W4200183429 creator A5079162272 @default.
• W4200183429 date "2021-12-17" @default.
• W4200183429 modified "2023-10-05" @default.
• W4200183429 title "Using RNA-Seq to Investigate Immune-Metabolism Features in Immunocompromised Patients With Sepsis" @default.
• W4200183429 cites W1990237691 @default.
• W4200183429 cites W2015224936 @default.
• W4200183429 cites W2089041106 @default.
• W4200183429 cites W2090751965 @default.
• W4200183429 cites W2097948046 @default.
• W4200183429 cites W2100980426 @default.
• W4200183429 cites W2101748726 @default.
• W4200183429 cites W2102278945 @default.
• W4200183429 cites W2104989405 @default.
• W4200183429 cites W2127381016 @default.
• W4200183429 cites W2128349740 @default.
• W4200183429 cites W2130410032 @default.
• W4200183429 cites W2138207763 @default.
• W4200183429 cites W2144420540 @default.
• W4200183429 cites W2144589352 @default.
• W4200183429 cites W2151422820 @default.
• W4200183429 cites W2152239989 @default.
• W4200183429 cites W2159675211 @default.
• W4200183429 cites W2274346642 @default.
• W4200183429 cites W2280404143 @default.
• W4200183429 cites W2296531152 @default.
• W4200183429 cites W2301209689 @default.
• W4200183429 cites W2530492696 @default.
• W4200183429 cites W2541557701 @default.
• W4200183429 cites W2552229806 @default.
• W4200183429 cites W2724317418 @default.
• W4200183429 cites W2728919089 @default.
• W4200183429 cites W2750720130 @default.
• W4200183429 cites W2757829688 @default.
• W4200183429 cites W2763557630 @default.
• W4200183429 cites W2787981407 @default.
• W4200183429 cites W2793177906 @default.
• W4200183429 cites W2811427324 @default.
• W4200183429 cites W2898483928 @default.
• W4200183429 cites W2901503524 @default.
• W4200183429 cites W2991130979 @default.
• W4200183429 cites W2998853022 @default.
• W4200183429 cites W3004917317 @default.
• W4200183429 cites W3006033724 @default.
• W4200183429 cites W3015567081 @default.
• W4200183429 cites W3032428915 @default.
• W4200183429 cites W3097692394 @default.
• W4200183429 cites W3120857229 @default.
• W4200183429 doi "https://doi.org/10.3389/fmed.2021.747263" @default.
• W4200183429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34977060" @default.
• W4200183429 hasPublicationYear "2021" @default.
• W4200183429 type Work @default.
• W4200183429 citedByCount "5" @default.
• W4200183429 countsByYear W42001834292022 @default.
• W4200183429 countsByYear W42001834292023 @default.
• W4200183429 crossrefType "journal-article" @default.
• W4200183429 hasAuthorship W4200183429A5002450833 @default.
• W4200183429 hasAuthorship W4200183429A5006795311 @default.
• W4200183429 hasAuthorship W4200183429A5016522091 @default.
• W4200183429 hasAuthorship W4200183429A5037349631 @default.
• W4200183429 hasAuthorship W4200183429A5041558983 @default.
• W4200183429 hasAuthorship W4200183429A5042866937 @default.
• W4200183429 hasAuthorship W4200183429A5065486587 @default.
• W4200183429 hasAuthorship W4200183429A5079162272 @default.
• W4200183429 hasBestOaLocation W42001834291 @default.
• W4200183429 hasConcept C104317684 @default.
• W4200183429 hasConcept C126322002 @default.
• W4200183429 hasConcept C150194340 @default.
• W4200183429 hasConcept C162317418 @default.
• W4200183429 hasConcept C177713679 @default.
• W4200183429 hasConcept C203014093 @default.
• W4200183429 hasConcept C2777465075 @default.
• W4200183429 hasConcept C2778384902 @default.
• W4200183429 hasConcept C2987404301 @default.
• W4200183429 hasConcept C54355233 @default.
• W4200183429 hasConcept C71924100 @default.
• W4200183429 hasConcept C86803240 @default.
• W4200183429 hasConcept C8891405 @default.
• W4200183429 hasConceptScore W4200183429C104317684 @default.
• W4200183429 hasConceptScore W4200183429C126322002 @default.
• W4200183429 hasConceptScore W4200183429C150194340 @default.
• W4200183429 hasConceptScore W4200183429C162317418 @default.
• W4200183429 hasConceptScore W4200183429C177713679 @default.
• W4200183429 hasConceptScore W4200183429C203014093 @default.
• W4200183429 hasConceptScore W4200183429C2777465075 @default.
• W4200183429 hasConceptScore W4200183429C2778384902 @default.
• W4200183429 hasConceptScore W4200183429C2987404301 @default.
• W4200183429 hasConceptScore W4200183429C54355233 @default.
• W4200183429 hasConceptScore W4200183429C71924100 @default.
• W4200183429 hasConceptScore W4200183429C86803240 @default.
• W4200183429 hasConceptScore W4200183429C8891405 @default.
• W4200183429 hasFunder F4320322108 @default.

• next